Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial
Stéphane de Botton(Université Paris-Saclay), Pierre Fenaux(Saint Louis University Hospital), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Christine Chomienne(Inserm), Jesús F. San Miguel(Clinica Universidad de Navarra), Valérie Coiteux(Hôpital Claude Huriez), D. Cony Makhoul(University of Bern), Anne Vekhoff(Hôtel-Dieu de Paris), Martine Gardembas(Centre Hospitalier Universitaire d'Angers), Sylvie Chevret(Saint Louis University Hospital), Claude Gardin(Sorbonne Université), Oumédaly Reman(University of Bern), A. Stamatoulas(University of Bern), Denis Caillot, E. Condé(University of Bern), Javier de la Serna(Hospital Universitario 12 De Octubre), Martin F. Fey(European Union), L Degos(Centre Hospitalier Universitaire de Lille), F. Lefrere(University of Bern), Hervé Dombret(University of London Institute in Paris), A. Guerci(University of Bern)
Cited by 71
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k